EBIT at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Plus components not separately reported this period.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s EBIT?
- AbCellera Biologics Inc. (ABCL) reported EBIT of -$57.52M in Q1 2026.
- How has AbCellera Biologics Inc.'s EBIT changed year-over-year?
- AbCellera Biologics Inc.'s EBIT increased by 8.2% year-over-year, from -$62.66M to -$57.52M.
- What is the long-term trend for AbCellera Biologics Inc.'s EBIT?
- Over 3 years (2021 to 2025), AbCellera Biologics Inc.'s EBIT has grown at a 2.0% compound annual growth rate (CAGR), from $204.5M to -$217.11M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.